Patent · US Active

Composition comprising recombinant nucleic acid encoding Sox2, Oct-4, Nanog and Lin28

US8183038B2 · kind B2 · utility

18Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2010
Grant dateMay 22, 2012
Priority date
Expiry dateMar 18, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/027
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.